Press Releases< /span>
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Mar 19, 2012
Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF.PK) today announced that its partner, Medical Futures Inc. ("Medical Futures"), has launched Durela™ (extended-release tramadol) in Canada. The...
-
Feb 22, 2012
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the fourth quarter and fiscal year ended December 31, 2011. Fiscal 2011 Summary Completed...
-
Feb 15, 2012
- Financial results to be released February 22, 2012 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Feb. 15, 2012 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) will host a conference call...
-
Feb 6, 2012
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it reached a sales milestone for Lipofen®, the Company's fenofibrate product. This one-time milestone, which is based on sales...
-
Jan 30, 2012
Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that its New Drug Submission for CIP-ISOTRETINOIN, a novel, patented formulation of the acne medication...
-
Dec 21, 2011
Toronto Stock Exchange Symbol: DND - Company receives US$1.0 million milestone - - Company also files New Drug Submission with Health Canada - MISSISSAUGA, ON, Dec. 21, 2011 /CNW/ - Cipher...
-
Nov 23, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has submitted an amendment to its pending New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for...
-
Oct 26, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three months ended September 30, 2011 ("Q3 2011"). Q3 2011 Summary Cipher's U.S. marketing...
-
Oct 19, 2011
- Third quarter financial results to be released October 26, 2011 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Oct. 19, 2011 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...
-
Sep 26, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that it has entered into a distribution and supply agreement with Medical Futures Inc. ("Medical Futures"), a...
-
Sep 7, 2011
Cipher Pharmaceuticals Inc. (TSX: DND), announced today that Larry Andrews, President and Chief Executive Officer, is presenting at the Rodman & Renshaw Annual Global Investment Conference, which...
-
Aug 31, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that Health Canada has approved CIP-TRAMADOL ER, the Company's extended-release tramadol product, for the treatment of moderate to moderately...
-
Jul 26, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and six months ended June 30, 2011 ("Q2 2011"). Q2 2011 Summary Licensed the U.S....
-
Jul 7, 2011
- Second quarter financial results to be released July 26, 2011 - Toronto Stock Exchange Symbol: DND MISSISSAUGA,ON, July 7, 2011 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...
-
Jun 29, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that it has entered into a definitive distribution and supply agreement with Vertical Pharmaceuticals, Inc....
-
Jun 7, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) today provided top-line safety and efficacy results from the Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of...
-
May 12, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three months ended March 31, 2011 ("Q1 2011"). The first quarter of 2011 represents the...
-
May 5, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) today announced it will host a conference call for its Q1 2011 financial results and hold an Annual & Special Meeting of Shareholders on Thursday, May 12,...
-
Mar 9, 2011
- Results highlighted by 70% increase in revenue - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, March 9 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and...
-
Feb 23, 2011
- Fourth quarter and year-end financial results to be released March 9, 2011 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Feb. 23 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host...
-
Oct 29, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of...
-
Oct 27, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and nine months ended September 30, 2010. Q3 2010 Summary --------------- - Net revenue...
-
Oct 18, 2010
- Third quarter financial results to be released October 27, 2010 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Oct. 18 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...
-
Oct 7, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that the U.S. Patent and Trademark Office has issued a Patent Notice of Allowance for CIP-TRAMADOL ER, the Company's extended-release...
-
Oct 1, 2010
Cipher Pharmaceuticals Inc. (TSX: DND), announced today that Larry Andrews, President and Chief Executive Officer, is presenting at the 9th Annual BIO Investor Forum, which is being held in San...